A case of acquired hemophilia caused by factor VIII inhibitor with rheumatoid arthritis, successfully treated with immunosuppressive treatment and recombinant activated factor VII

By Sato Takeo   Hagiwara Kiyofumi   Chikazoe Junnichi   Nakagawa Yasunori   Akiyama Osamu  

Modern Rheumatology, Vol. 14, Iss. 4, 2004-09 ,pp. : 320-322

Springer Publishing Company

Access to resources Recommend Favorite

RECOMBINANT HUMAN TISSUE FACTOR PATHWAY INHIBITOR AS A POSSIBLE ANTICOAGULANT TARGETING HEPATIC SINUSOIDAL WALLS

By Yamanobe F.   Mochida S.   Ohno A.   Ishikawa K.   Fujiwara K.  

Thrombosis Research, Vol. 85, Iss. 6, 1997-03 ,pp. : 493-501

Elsevier

Access to resources Recommend Favorite

A Kinetic Analysis of the Interaction of Human Recombinant Tissue Factor Pathway Inhibitor with Factor Xa Utilizing an Immunoassay and the Effect of Antithrombin III/Heparin on the Complex Formation - one N- and two O-linked carbohydrate chains are located between Kunitz domains 2 and 3 and one N-linked carbohydrate chain is in Kunitz domain 2

By Kamikubo Y.-i.   Hamuro T.   Takemoto S.   Nakahara Y.   Kamei S.   Nakagaki T.   Miyamoto S.   Funatsu A.   Kato H.  

Thrombosis Research, Vol. 89, Iss. 4, 1998-02 ,pp. : 179-186

Elsevier

Access to resources Recommend Favorite

In Hemophilia A and Autoantibody Inhibitor Patients: The Factor VIII A2 Domain and Light Chain Are Most Immunogenic

By Scandella D.H.   Nakai H.   Felch M.   Mondorf W.   Scharrer I.   Hoyer L.W.   Saenko E.L.  

Thrombosis Research, Vol. 101, Iss. 5, 2001-03 ,pp. : 377-385

Elsevier

Access to resources Recommend Favorite

Recombinant Human Insulin-Like Growth Factor-1: A New Cardiovascular Disease Treatment Option?

By  

Cardiovascular & Hematological Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Cardiovascular & Hematological Agents), Vol. 6, Iss. 4, 2008-01 ,pp. : 258-271

Bentham Science Publishers

Access to resources Recommend Favorite